You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 16, 2026
Sale
Calculated transaction value
$327.97K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 15, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$500.35
Sep 15, 2026
First close after public filing
$497.27
Sep 17, 2026
30-day return after filing
+7.21%
Through Oct 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 650 shares @ $504.57
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000142
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$5.88M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 15, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $389.82K |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $1.86M |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $1.35M |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $414.62K |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $425.71K |
| United Therapeutics Corp UTHR Current | Sale | Sep 15, 2026 | $327.97K |
| United Therapeutics Corp UTHR | Exercise | Sep 15, 2026 | $0 |